Praxis Precision Medicines Inc [PRAX] stock is trading at $88.23, up 5.68%. An important factor to consider is whether the stock is rising or falling in short-term value. The PRAX shares have gain 19.20% over the last week, with a monthly amount glided 9.02%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Praxis Precision Medicines Inc [NASDAQ: PRAX] stock has seen the most recent analyst activity on August 05, 2024, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $134. Previously, Needham started tracking the stock with Buy rating on June 24, 2024, and set its price target to $145. On June 18, 2024, Guggenheim initiated with a Buy rating and assigned a price target of $155 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $117 on May 01, 2024. Truist initiated its recommendation with a Buy and recommended $10 as its price target on September 19, 2023. Wedbush downgraded its rating to Neutral for this stock on June 06, 2022, but kept the price target unchanged to $4. In a note dated December 16, 2021, H.C. Wainwright initiated an Buy rating and provided a target price of $48 on this stock.
Praxis Precision Medicines Inc [PRAX] stock has fluctuated between $33.01 and $86.93 over the past year. Currently, Wall Street analysts expect the stock to reach $73.77 within the next 12 months. Praxis Precision Medicines Inc [NASDAQ: PRAX] shares were valued at $88.23 at the most recent close of the market. An investor can expect a potential drop of -16.39% based on the average PRAX price forecast.
Analyzing the PRAX fundamentals
Praxis Precision Medicines Inc [NASDAQ:PRAX] reported sales of 1.60M for the trailing twelve months, which represents a drop of -35.47%. Gross Profit Margin for this corporation currently stands at 0.79% with Operating Profit Margin at -102.19%, Pretax Profit Margin comes in at -94.09%, and Net Profit Margin reading is -94.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.36, Equity is -0.55 and Total Capital is -0.43. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 83.88 points at the first support level, and at 79.53 for the second support level. However, for the 1st resistance point, the stock is sitting at 90.42, and for the 2nd resistance point, it is at 92.61.
Ratios To Look Out For
For context, Praxis Precision Medicines Inc’s Current Ratio is 10.96. On the other hand, the Quick Ratio is 10.96, and the Cash Ratio is 5.13. Considering the valuation of this stock, the price to sales ratio is 1027.76, the price to book ratio is 4.10.
Transactions by insiders
Recent insider trading involved Nemiroff Alex, General Counsel and Secretary, that happened on Nov 14 ’24 when 8239.0 shares were sold. Principal Accounting Officer, Mastrocola Lauren completed a deal on Nov 14 ’24 to sell 5188.0 shares. Meanwhile, Officer Mastrocola Lauren bought 5189.0 shares on Nov 14 ’24.
